Navigation Links
Halozyme Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/5/2010

on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.Halozyme ContactRobert H. UhlSenior Director, Investor Relations(858) 704-8264ruhl@halozyme.comHalozyme Therapeutics, Inc.Condensed Consolidated Statements of OperationsThree Months EndedNine Months EndedSeptember 30, September 30,2010200920102009(unaudited)(unaudited)(unaudited)(unaudited)REVENUES:Product sales

$
98,100$
411,109$
95,440$
9,267Revenues under collaborative agreements

3,298,4072,617,7769,356,1516,558,145Total revenues

3,396,5073,028,88510,051,5917,227,412OPERATING EXPENSES:Cost of product sales

7,214102,63896,413151,939Research and development

12,448,86513,162,74835,840,47541,763,972Selling, general and administrative

3,374,0693,703,09910,488,56811,093,563Total operating expenses

15,830,14816,968,48546,425,45653,009,474OPERATING LOSS

(12,433,641)(13,939,600)(36,373,865)(45,782,062)Interest and other income, net

24,06529,31825,88986,391NET LOSS

$ (12,409,576)$ (13,910,282)$ (36,347,976)$ (45,695,671)Basic and diluted net loss per share

$
(0.13)$
(0.16)$
(0.39)$
(0.54)Shares used in computing basic and dilutednet loss per share

93,626,89389,570,54092,342,66585,086,456Halozyme Therapeutics, Inc.Condensed Consolidated Balance SheetsSeptember 30,December 31,20102009(unaudited)ASSETSCurrent assets:Cash and cash equivalents

$
89,840,588$   67,464,506Accounts receivable

2,622,0764,243,909Inventory

1,076,5801,159,551Prepaid expenses and other assets

4,891,5561,573,777Total current assets

98,430,80074,441,743Property and equipment, net

1,960,9352,708,016Total Assets

$   100,391,735$   77,149,759LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
,828,069$
2,820,491Accrued expenses

5,052,7236,083,854Deferred revenue

4,900
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
2. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
3. Halozyme Therapeutics to Present at Upcoming Investor Conferences
4. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
5. Halozyme Therapeutics to Host Research Day for Investors and Analysts
6. Halozyme Therapeutics to Present at Upcoming Investor Conferences
7. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
8. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
9. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
10. Halozyme Receives $5.5 Million Payment From Baxter
11. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Navitas, a leading Regulatory Service provider, today announced that it ... Bogota, Colombia . Navitas, expansion into Latin ... Colombia , the third largest economy in ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... to communicate with Navitas regulatory professionals in close to or the same ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Alexander Group, a 30-year ... industries alike-- typically known for its consummate professionalism-- embarks each year in a ... break from their day jobs. , "Our motto has always been work hard ...
(Date:7/3/2015)... Forskere kan ansøge ... http://www.openinnovationinscience.at om efteruddannelsesprogrammet "Lab for Open ... Wien .  ... og videnskabsmænd foretaget af Ludwig Boltzmann Gesellschaft ... sundhedsvidenskaben manglen på incitamenter til at undersøge ...
(Date:7/2/2015)... Calif. (PRWEB) , ... July 02, 2015 , ... Sleepless ... improve an individual’s quality of sleep, launched its Indiegogo campaign on June 23. Sound ... Luzi's voice command technology makes it effortless to use, while the integration of the ...
Breaking Biology Technology:Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3The Alexander Group Declares Their Independence with a Bit of Levity 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3
... - Oncothyreon Inc. (Nasdaq: ONTY ) announced ... Officer, will present at the 5th Annual JMP Securities ... 2010, at 10:30 a.m. Eastern Time. A ... be accessible by visiting the Oncothyreon website www.oncothyreon.com ...
... 27 Cellectis bioresearch, the specialist in genome customization ... announce the launch of its e-store, with approximately one ... new functional and intuitive website. Launched in ... of targeted integration kits, which offer a simple, effective ...
... Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion)... -- TCT 2010, WASHINGTON, September 24, ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Biology Technology:Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store 2Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store 3Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 2Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 3Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 4Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 5Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 6Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 7
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/25/2015)... N.J. , June 25, 2015  TAKE Solutions ... a patent by the United States Patent and Trademark ... Standardization". This process leverages TAKE Solutions, Clinical Accelerators to ... over 50% (when compared to standardization without the accelerators), ... At the heart of ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2
... new and environmentally friendly process for producing biodiesel fuel ... pounds of poultry industry waste that accumulate annually in ... the July 22 issue of ACS, Journal of ... In the study Mano Misra, Susanta Mohapatra, Narasimharao Kondamudi, ...
... Applying biological molecules from cell membranes to the ... the very basics of cell-to-cell interaction. Two ... biophysicist and colleagues suggest that putting lipids and ... lead to new classes of self-assembling materials for ...
... defective mitochondrial protein called MCLK1 produce elevated amounts of ... according to a study in this week,s JBC these ... longer than normal mice. Mitochondrial oxidative stress is ... reactive oxygen species produced by mitochondria while they make ...
Cached Biology News:New windows opened on cell-to-cell interactions 2New windows opened on cell-to-cell interactions 3
...
Normal Hamster Serum...
... The P5T Series Short Stroke Thrust ... stroke applications where mounting envelopes are limited ... wear bands and internal bumpers provide millions ... applications., Choice of composite bushings or ...
Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
Biology Products: